Molecular genetics of oculocutaneous albinism
- PMID: 8217557
Molecular genetics of oculocutaneous albinism
Abstract
Oculocutaneous albinism (OCA) is a group of autosomal recessive disorders characterized by deficient synthesis of melanin pigment. Type I (tyrosinase-deficient) OCA results from deficient enzymatic activity of tyrosinase, which catalyzes at least three steps in the melanin biosynthetic pathway. Type II (tyrosinase-positive) OCA results from abnormalities of the "P" polypeptide. Recent application of molecular genetic techniques to the study of these disorders has led to extraordinary advances in knowledge of their molecular pathogenesis, paving the way to improved diagnosis, carrier detection, and even treatment.
Similar articles
-
Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.Am J Med Genet. 1992 Jul 15;43(5):865-71. doi: 10.1002/ajmg.1320430523. Am J Med Genet. 1992. PMID: 1642278
-
Molecular genetics of oculocutaneous albinism.Hum Mol Genet. 1994;3 Spec No:1469-75. doi: 10.1093/hmg/3.suppl_1.1469. Hum Mol Genet. 1994. PMID: 7849740 Review.
-
[Human oculocutaneous albinism. From clinical observation to molecular biology].Bull Soc Pathol Exot. 1993;86(5):313-26. Bull Soc Pathol Exot. 1993. PMID: 8124097 Review. French.
-
OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene.Ann Hum Genet. 2006 Sep;70(Pt 5):623-30. doi: 10.1111/j.1469-1809.2006.00247.x. Ann Hum Genet. 2006. PMID: 16907708
-
Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.Hum Mutat. 1993;2(1):1-6. doi: 10.1002/humu.1380020102. Hum Mutat. 1993. PMID: 8477259
Cited by
-
An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids.Am J Hum Genet. 1995 Mar;56(3):586-91. Am J Hum Genet. 1995. PMID: 7887411 Free PMC article.
-
Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.Orphanet J Rare Dis. 2012 Jun 26;7:44. doi: 10.1186/1750-1172-7-44. Orphanet J Rare Dis. 2012. PMID: 22734612 Free PMC article.
-
Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.J Clin Invest. 2011 Oct;121(10):3914-23. doi: 10.1172/JCI59372. J Clin Invest. 2011. PMID: 21968110 Free PMC article.
-
Albinism: modern molecular diagnosis.Br J Ophthalmol. 1998 Feb;82(2):189-95. doi: 10.1136/bjo.82.2.189. Br J Ophthalmol. 1998. PMID: 9613388 Free PMC article. Review. No abstract available.
-
[Clinical and molecular genetic analysis of Angelman syndrome with oculocutaneous albinism type 2: A case report and literature review].Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Feb 18;55(1):181-185. doi: 10.19723/j.issn.1671-167X.2023.01.028. Beijing Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 36718709 Free PMC article. Review. Chinese.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources